Disruption of blood-brain barrier by focused ultrasound for targeted drug delivery to the brain

Neuromethods

Volumn 45, Issue , 2010, Pages 35-62

  Vykhodtseva, Natalia ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

BBB disruption; Blood brain barrier (BBB); Drug delivery to CNS; Ultrasound

Indexed keywords

AMYLOID; ANTINEOPLASTIC AGENT; DOXORUBICIN; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BETA AMYLOID PROTEIN; PERFLUTREN; TRASTUZUMAB; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD BRAIN BARRIER; BRAIN; CELL TRANSPORT; DRUG DELIVERY SYSTEM; DRUG TARGETING; ELECTRON MICROSCOPY; GLIOMA; INTERMETHOD COMPARISON; INVASIVE PROCEDURE; MEMBRANE DAMAGE; MICROBUBBLE; MOLECULAR IMAGING; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; RAT; REVIEW; ULTRASOUND;

ANIMALIA;

EID: 73849108808     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-60761-529-3_3     Document Type: Review

References (74)

1. Hynynen, K.,McDannold,N., Vykhodtseva, N., and Jolesz, F.A., Noninvasive MR imaging- guided focal opening of the bloodbrain barrier in rabbits, Radiology, 220 (2001) 640-646.
2. Hynynen, K., McDannold, N., Sheikov, N.A., Jolesz, F.A., and Vykhodtseva, N., Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications, NeuroImage, 24 (2005) 12-20.
3. Hynynen, K.,McDannold,N., Vykhodtseva, N., Raymond, S., Weissleder, R., Jolesz, F.A., and Sheikov, N., Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery, J. Neurosurg., 105 (2006) 445-454.
4. Kinoshita, M., McDannold, N., Jolesz, F.A., and Hynynen, K., Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasoundinduced blood-brain barrier disruption, Proc. Natl. Acad. Sci. U. S. A., 103 (2006) 11719-11723.
5. Kinoshita, M., McDannold, N., Jolesz, F.A., and Hynynen, K., Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound, Biochem. Biophys. Res. Commun., 340 (2006) 1085-1090.
6. Sheikov, N., McDannold, N., Vykhodtseva, N., Jolesz, F., and Hynynen, K., Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles, Ultrasound Med. Biol., 30 (2004) 979-989.
7. Sheikov, N., McDannold, N., Jolesz, F., Zhang, Y.Z., Tam, K., and Hynynen, K., Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the bloodbrain barrier, Ultrasound Med. Biol., 32 (2006) 1399-1409.
8. Treat, L.H., McDannold, N., Vykhodtseva, N., Zhang, Y., Tam, K., and Hynynen, K., Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRIguided focused ultrasound, Int. J. Cancer, 121 (2007) 901-907.
9. Choi, J.J., Pernot, M., Small, S.A., and Konofagou, E.E., Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice, Ultrasound Med. Biol., 33 (2007) 95-104.
10. Yang, F.Y., Fu, W.M., Yang, R.S., Liou, H.C., Kang, K.H., and Lin, W.L., Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption, Ultrasound Med. Biol., 33 (2007) 1421-1427.
11. Hynynen, K., Clement, G.T., McDannold, N., Vykhodtseva, N., King, R., White, P.J., Vitek, S., and Jolesz, F.A., 500-element ultrasound phased array system for noninvasive focal surgery of the brain: a preliminary rabbit study with ex vivo human skulls, Magn. Reson. Med., 52 (2004) 100-107.
12. Aubry, J.F., Tanter, M., Pernot, M., Thomas, J.L., and Fink, M., Experimental demonstration of noninvasive transskull adaptive focusing based on prior computed tomography scans, J. Acoust. Soc. Am., 113 (2003) 84-93.
13. Pernot, M., Aubry, J.F., Tanter, M., Thomas, J.L., and Fink, M., High power transcranial beam steering for ultrasonic brain therapy, Phys. Med. Biol., 48 (2003) 2577-2589.
14. Lele, P.P., Advanced ultrasonic techniques for local tumor hyperthermia, Radiol. Clin. North Am., 27 (1989) 559-575.
15. Hynynen, K. and Lulu, B.A., Hyperthermia in cancer treatment, Invest. Radiol., 25 (1990) 824-834.
16. Diederich, C.J. and Hynynen, K., Ultrasound technology for hyperthermia, Ultrasound Med. Biol., 25 (1999) 871-887.
17. Arthur, R.M., Straube, W.L., Trobaugh, J.W., and Moros, E.G., Non-invasive estimation of hyperthermia temperatures with ultrasound, Int. J. Hyperthermia, 21 (2005) 589-600.
18. Fennessy, F.M. and Tempany, C.M., MRIguided focused ultrasound surgery of uterine leiomyomas, Acad. Radiol., 12 (2005) 1158-1166.
19. Fennessy, F.M., Tempany, C.M., McDannold, N.J., So, M.J., Hesley, G., Gostout, B., Kim, H.S., Holland, G.A., Sarti, D.A., Hynynen, K., Jolesz, F.A., and Stewart, E.A., Uterine leiomyomas: MR imaging-guided focused ultrasound surgery - results of different treatment protocols, Radiology, 243 (2007) 885-893.
20. Rabinovici, J., Inbar, Y., Revel, A., Zalel, Y., Gomori, J.M., Itzchak, Y., Schiff, E., and Yagel, S., Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance-guided focused ultrasound surgery, Ultrasound Obstet. Gynecol., 30 (2007) 771-777.
21. Zhang, L., Chen, W.Z., Liu, Y.J., Hu, X., Zhou, K., Chen, L., Peng, S., Zhu, H., Zou, H.L., Bai, J., and Wang, Z.B., Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus, Eur. J. Radiol., (2008).
22. Hesley, G.K., Gorny, K.R., Henrichsen, T.L., Woodrum, D.A., and Brown, D.L., A clinical review of focused ultrasound ablation with magnetic resonance guidance: an option for treating uterine fibroids, Ultrasound Q., 24 (2008) 131-139.
23. Fukunishi, H., Funaki, K., Sawada, K., Yamaguchi, K., Maeda, T., and Kaji, Y., Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases, J. Minim. Invasive. Gynecol., 15 (2008) 571-579.
24. Yang, Z., Cao, Y.D., Hu, L.N., and Wang, Z.B., Feasibility of laparoscopic high-intensity focused ultrasound treatment for patients with uterine localized adenomyosis, Fertil. Steril. (2008).
25. Funaki, K., Fukunishi, H., Funaki, T., and Kawakami, C., Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: from six to twelve months after volume reduction, J. Minim. Invasive. Gynecol., 14 (2007) 616-621.
26. Furusawa, H., Namba, K., Thomsen, S., Akiyama, F., Bendet, A., Tanaka, C., Yasuda, Y., and Nakahara, H., Magnetic resonanceguided focused ultrasound surgery of breast cancer: reliability and effectiveness, J. Am. Coll. Surg., 203 (2006) 54-63.
27. Wu, F., Wang, Z.B., Cao, Y.D., Xu, Z.L., Zhou, Q., Zhu, H., and Chen, W.Z., Heat fixation of cancer cells ablated with highintensity- focused ultrasound in patients with breast cancer, Am. J. Surg., 192 (2006) 179-184.
28. Wu, F., ter Haar, G., and Chen, W.R., High-intensity focused ultrasound ablation of breast cancer, Expert. Rev. Anticancer Ther., 7 (2007) 823-831.
29. Hacker, A., Michel, M.S., Marlinghaus, E., Kohrmann, K.U., and Alken, P., Extracorporeally induced ablation of renal tissue by high-intensity focused ultrasound, BJU Int., 97 (2006) 779-785.
30. Klingler, H.C., Susani, M., Seip, R., Mauermann, J., Sanghvi, N., and Marberger, M.J., A novel approach to energy ablative therapy of small renal tumours: laparoscopic highintensity focused ultrasound, Eur. Urol., 53 (2008) 810-816.
31. Kohrmann, K.U., Michel, M.S., Gaa, J., Marlinghaus, E., and Alken, P., High intensity focused ultrasound as noninvasive therapy for multilocal renal cell carcinoma: case study and review of the literature, J. Urol., 167 (2002) 2397-2403.
32. Erce, C. and Parks, R.W., Interstitial ablative techniques for hepatic tumours, Br. J. Surg., 90 (2003) 272-289.
33. Okada, A., Murakami, T., Mikami, K., Onishi, H., Tanigawa, N., Marukawa, T., and Nakamura, H., A case of hepatocellular carcinoma treated by MR-guided focused ultrasound ablation with respiratory gating, Magn. Reson.Med. Sci., 5 (2006) 167-171.
34. Barqawi, A.B. and Crawford, E.D., Emerging role of HIFU as a noninvasive ablative method to treat localized prostate cancer, Oncology (Williston. Park), 22 (2008) 123-129.
35. Muto, S., Yoshii, T., Saito, K., Kamiyama, Y., Ide, H., and Horie, S., Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer, Jpn. J. Clin. Oncol., 38 (2008) 192-199.
36. Koch, M.O., Gardner, T., Cheng, L., Fedewa, R.J., Seip, R., and Sanghvi, N.T., Phase I/II trial of high intensity focused ultrasound for the treatment of previously untreated localized prostate cancer, J. Urol., 178 (2007) 2366-2370.
37. Rouviere, O., Souchon, R., Salomir, R., Gelet, A., Chapelon, J.Y., and Lyonnet, D., Transrectal high-intensity focused ultrasound ablation of prostate cancer: effective treatment requiring accurate imaging, Eur. J. Radiol., 63 (2007) 317-327.
38. Wu, F., Wang, Z.B., Zhu, H., Chen, W.Z., Zou, J.Z., Bai, J., Li, K.Q., Jin, C.B., Xie, F.L., and Su, H.B., Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience, Radiology, 236 (2005) 1034-1040.
39. Catane, R., Beck, A., Inbar, Y., Rabin, T., Shabshin, N., Hengst, S., Pfeffer, R.M., Hanannel, A., Dogadkin, O., Liberman, B., and Kopelman, D., MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases - preliminary clinical experience, Ann. Oncol., 18 (2007) 163-167.
40. Liberman, B., Gianfelice, D., Inbar, Y., Beck, A., Rabin, T., Shabshin, N., Chander, G., Hengst, S., Pfeffer, R., Chechick, A., Hanannel, A., Dogadkin, O., and Catane, R., Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study, Ann. Surg. Oncol., 16 (2009) 140-146.
41. Clement, G.T. and Hynynen, K., A noninvasive method for focusing ultrasound through the human skull, Phys. Med. Biol., 47 (2002) 1219-1236.
42. Pernot, M., Aubry, J.F., Tanter, M., Marquet, F., Montaldo, G., Boch, A.L., Kujas, M., Seilhean, D., and Fink, M., High power phased array prototype for clinical high intensity focused ultrasound: applications to transcostal and transcranial therapy. Conf. Proc. IEEE Eng Med Biol Soc. (2007), 234-237.
43. Nyborg, W.L., Biological effects of ultrasound: development of safety guidelines. Part II: general review, Ultrasound Med. Biol., 27 (2001) 301-333.
44. Hsieh, D.Y. and Plesset, M.S., Theory of rectified diffusion of mass into gas bubbles, J. Acoust. Soc. Am., 33 (1961) 206-211.
45. Nyborg, W.L. and Acoustic, S. In: W.P. Mason (Ed.), Physical Acoustics, Vol.2B, Academic Press, New York (1965).
46. Miller, D.L., A review of the ultrasonic bioeffects of microsonation, gas-body activation, and related cavitation-like phenomena, Ultrasound Med. Biol., 13 (1987) 443-470.
47. Krizanac-Bengez, L., Mayberg, M.R., and Janigro, D., The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology, Neurol. Res., 26 (2004) 846-853.
48. Leighton, T. The Acoustic Bubble, Academic Press, San Diego, CA (1994).
49. Mihran, R.T., Barnes, F.S., and Wachtel, H., Transient modification of nerve excitability in vitro by single ultrasound pulses, Biomed. Sci. Instrum., 26 (1990) 235-246.
50. Hamill, O.P., Twenty odd years of stretchsensitive channels, Pflugers Arch., 453 (2006) 333-351.
51. Edmonds, P.D. and Sancier, K.M., Evidence for free radical production by ultrasonic cavitation in biological media, Ultrasound Med. Biol., 9 (1983) 635-639.
52. Apfel, R.E., Acoustic cavitation: a possible consequence of biomedical uses of ultrasound, Br. J. Cancer. Suppl., 45 (1982) 140-146.
53. Flynn, H.G., Generation of transient cavities in liquids by microsecond pulses of ultrasound, J. Acoust. Soc. Am., 72 (1982) 1926-1932.
54. Duck, F.A. Physical Properties of Tissue, Academic Press Inc., New York (1990).
55. Treat, L.H. Advances in targeted chemotherapy using MRI-guided focused ultrasound to disrupt the blood-brain barrier. PhD Thesis, Massachusetts Institute of Technology, USA. 2009.
56. Hynynen, K., Macromolecular delivery across the blood-brain barrier, Methods Mol. Biol., 480 (2009) 175-185.
57. Goss, S.A., Johnston, R.L., and Dunn, F., Comprehensive compilation of empirical ultrasonic properties of mammalian tissues, J. Acoust. Soc. Am., 64 (1978) 423-457.
58. Hynynen, K., Vykhodtseva, N.I., Chung, A.H., Sorrentino, V., Colucci, V., and Jolesz, F.A., Thermal effects of focused ultrasound on the brain: determination with MR imaging, Radiology, 204 (1997) 247-253.
59. Ishihara, Y., Calderon, A., Watanabe, H., Okamoto, K., Suzuki, Y., and Kuroda, K., A precise and fast temperature mapping using water proton chemical shift, Magn. Reson. Med., 34 (1995) 814-823.
60. Hindman, J.C., Proton resonance shift of water in the gas and liquid states, J. Chem. Phys., 44 (1966) 4582-4592.
61. Bakay, L., Hueter, T.F., Ballantine, H.T. Jr., and Sosa, D., Ultrasonically produced changes in the blood-brain barrier, Arch. Neurol. Psychat., 76 (1956) 457-467.
62. Treat, L.H., Zhang, Y., McDannold, N., and Hynynen, K. Impact of focused ultrasound- enhanced drug delivery on survival in rats with glioma. Proceedings of the 8th International Symposium on Therapeutic Ultrasound./Minneapolis, Minnesota, USA. Ebbini, E. S. 2008.
63. Treat, L.H., Zhang, Y., McDannold, N., and Hynynen, K., MRI-guided focused ultrasound enhanced chemotherapy of 9L rat gliosarcoma: Survival study. Proceedings of the 16th Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine. Toronto, Ontario, Canada. 2008:71.
64. Raymond, S.B., Treat, L.H., Dewey, J.D., McDannold, N.J., Hynynen, K., and Bacskai, B.J., Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer's disease mouse models, PLoS. ONE., 3 (2008) e2175.
65. Stan, A.C., Casares, S., Radu, D., Walter, G.F., and Brumeanu, T.D., Doxorubicininduced cell death in highly invasive human gliomas, Anticancer Res., 19 (1999) 941-950.
66. Gupta, B. and Torchilin, V.P., Monoclonal antibody 2C5-modified doxorubicinloaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice, Cancer Immunol. Immunother., 56 (2007) 1215-1223.
67. Cummings, J. and McArdle,C.S., Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug, Br. J Cancer, 53 (1986) 835-838.
68. Benz, C.C., O'Hagan, R.C., Richter, B., Scott, G.K., Chang, C.H., Xiong, X., Chew, K., Ljung, B.M., Edgerton, S., Thor, A., and Hassell, J.A., HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer, Oncogene, 15 (1997) 1513-1525.
69. Sheikov, N., McDannold, N., Sharma, S., and Hynynen, K., Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium, Ultrasound Med. Biol., 34 (2008) 1093-1104.
70. Raymond, S.B., Skoch, J., Bacskai, B.J., and Hynynen, K., Modular design for in vivo optical imaging and ultrasound treatment in the murine brain, IEEE Trans. Ultrason. Ferroelectr. Freq. Control, 54 (2007) 431-434.
71. Raymond, S.B., Skoch, J., Hynynen, K., and Bacskai, B.J., Multiphoton imaging of ultrasound/ Optison mediated cerebrovascular effects in vivo, J. Cereb. Blood Flow Metab., 27 (2007) 393-403.
72. Cline, H.E., Schenck, J.F., Watkins, R.D., Hynynen, K., and Jolesz, F.A., Magnetic resonance-guided thermal surgery, Magn. Reson. Med., 30 (1993) 98-106.
73. Hynynen, K., Darkazanli, A., Unger, E., and Schenck, J.F., MRI-guided noninvasive ultrasound surgery, Med. Phys., 20 (1993) 107-115.
74. Cline, H.E., Hynynen, K., Watkins, R.D., Adams, W.J., Schenck, J.F., Ettinger, R.H., Freund, W.R., Vetro, J.P., and Jolesz, F.A., Focused US system for MR imaging-guided tumor ablation, Radiology, 194 (1995) 731-737.